EP
ORGO icon

Essential Partners’s Organogenesis Holdings ORGO Stock Holding History

Essential Partners’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.2K Buy
907
+383
+73% +$936 ﹤0.01% 1934
2026
Q1 		$1.24K Sell
524
-279
-35% -$966 ﹤0.01% 2177
2025
Q4 		$4.16K Buy
803
+200
+33% +$969 ﹤0.01% 1505
2025
Q3 		$2.54K Buy
603
+28
+5% +$130 ﹤0.01% 1713
2025
Q2 		$2.1K Buy
+575
New +$2.14K ﹤0.01% 1303

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Essential Partners's ORGO Position: Q2 2026 in Review

Essential Partners increased its Organogenesis Holdings (ORGO) stake by 73% in Q2 2026, buying an estimated $936 and bringing the position to 907 shares worth $2.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1934.

Essential Partners first reported a position in ORGO in Q2 2025 and has held it in 5 quarters since. The position peaked at $4.16K in Q4 2025. 135 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

  • Essential Partners held 907 shares of Organogenesis Holdings worth $2.2K as of Q2 2026.
  • Essential Partners bought 383 Organogenesis Holdings shares in Q2 2026, an estimated $936.
  • Organogenesis Holdings made up ﹤0.01% of Essential Partners's portfolio in Q2 2026, its #1934 holding.
  • Essential Partners first reported a position in Organogenesis Holdings in Q2 2025 and has held it in 5 quarters since.
  • Essential Partners's Organogenesis Holdings position peaked at $4.16K in Q4 2025.
  • 135 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.